Speciality Chemicals Magazine SEP / OCT 2023 | Page 71

EVENT PREVIEW lounge . To qualify , firms must have fewer than 50 employees and sales of less than € 10 million / year , and have a product which is either in proof of concept , prototype or commercialised stage . They must also commit to attending in person .
As ever , the show has a wide range of free-to-attend conference content in multiple tracks . On the first morning , the presentations in the Next-Gen Biomanufacturing track in Room 4.3 of Conference Centre 4 are as follows :
• 11.00-11.15 : Keynote , Setting the scene for the biomanufacturing landscape , Sheila Ann Mikhail , former CEO , Asklepios BioPharmaceutical
• 11.15-11.35 : Process characterisation essentials for biologics manufacturing , Caroline Bonifacio , head – drug product development , Siegfried
• 11.40-12.00 : Speed to market : Pipeline acceleration strategies for biologics manufacturing , Magnus Blomberg , global supply network strategy director , AstraZeneca
• 12.05-12.25 : Biologics capability & capacity expansion driving shift to CRDMO models , Umesh Lal , director , Frost & Sullivan
• 12.30-12.50 : Advancing standards in biosimilar engineering , speaker tbc
• 12.55-13.40 : Panel discussion , Cell therapy manufacturing commercialisation : Strategy & challenges , featuring speakers from the session The other track on the morning of Day One in Room 4.4 is Formulating the Future . Presentations are as follows :
• 11.00-11.15 : Keynote , Setting the scene for drug formulation , speaker tbc
• 11.15-11.35 : Strategies for formulating future drug modalities , Camille Dumont , manager – custom applications , Lonza
• 11.40-12.00 : Leveraging the benefit of drug delivery & formulation to achieve acceptability in the target patient population , Sven Stegemann , CEO , Leibniz JointLab
• 12.05-12.25 : iGAL 2.0 – A precise & accurate metric for end-toend analysis of drug substance manufacturing from the supply chain perspective , Juan Colberg , senior director technology & innovation , global green chemistry leader , Pfizer
• 12.30-12.50 : The future of EU offpatent API manufacturing , Medicines for Europe , speaker tbc
• 12.55-13.40 : Panel session , Looking to the future – What ’ s next for the generic drugs market ? with speakers from the session
The afternoon of Day One has tracks on Partnering for Success and Creating a Circular Economy The schedule for the former in Room 4.3 is :
• 14.00-14.15 : Keynote address , Setting the scene for the CDMO landscape , speaker tbc
• 14.15-14.35 : CDMO 2.0 : Going beyond with next-generation technology , speaker tbc , Indena
• 14.40-15.00 : CDMO selection for the biotech : A practical guide , Julien Laizé , head of global CTM external manufacturing , Valneva
• 15.05-15.25 : Case study : Embracing the modern CDMO in pharma , Shilpl Ghosh , CDMO site management chapter lead ,
I 2
O , CDMO , Roche
• 15.30-15.50 : Maintaining a proactive relation in an outsourcing partnership to optimise manufacturing operations , Federica Fassetti , focus factory leader , Merck & Co .
• 15.55-16.45 : Panel : The CDMO outlook , chaired by Gil Roth of PBOA with panellists from the session For the latter track in Room 4.4 , the speakers include the following :
• 14.00-14.15 : Keynote address , Setting the scene for the sustainability landscape , Montse Montaner , chief sustainability officer , Novartis
• 14.40-15.00 : Decarbonising chemical supply chains with the product carbon footprint guideline , Mathias Lemke , head of sourcing – raw packaging material , Merck & Co .
• 15.30-15.50 : Putting ESG into practice : Creating responsible supply chains via common audit approaches , Enric Bosch Rado , global third party chemicals manager , Boehringer Ingelheim
• 15.55-16.45 : Panel : How pharma can build a meaningful Circular Economy , with panellists from the session The themes on the morning of Day Two are Manufacturing 4.0 and Future Therapies . Presentations in the former track , in Room 4.4 , are as follows :
• 11.00-11.15 : Keynote address , Setting the scene for drug
SEP / OCT 2023 SPECCHEMONLINE . COM
71